X-Square Capital’s Tenaya Therapeutics TNYA Stock Holding History

X-Square Capital’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$7K	–	180
2025 Q4	$7K	Hold	10,000	–	–	﹤0.01%	158
2025 Q3	$16K	Hold	10,000	–	–	0.01%	160
2025 Q2	$6K	Buy	+10,000	New	+$5.09K	﹤0.01%	159

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

X-Square Capital's TNYA Position: Q1 2026 in Review

X-Square Capital sold out of Tenaya Therapeutics (TNYA) in Q1 2026, closing a stake of 10,000 shares — an estimated $7K sold.

X-Square Capital first reported a position in TNYA in Q2 2025 and held it in 3 quarters. The position peaked at $16K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

X-Square Capital reported no remaining Tenaya Therapeutics position as of Q1 2026 after selling out during the quarter.
X-Square Capital sold 10,000 Tenaya Therapeutics shares in Q1 2026, an estimated $7K.
X-Square Capital first reported a position in Tenaya Therapeutics in Q2 2025 and held it in 3 quarters.
X-Square Capital's Tenaya Therapeutics position peaked at $16K in Q3 2025.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on X-Square Capital's 13F filing for Q1 2026, filed 15 May 2026.